1
|
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
|
Blood
|
2008
|
2.88
|
2
|
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.
|
Blood
|
2005
|
1.32
|
3
|
Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses.
|
Blood
|
2003
|
1.13
|
4
|
Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
|
Epigenetics
|
2009
|
0.99
|
5
|
Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling.
|
Blood
|
2004
|
0.97
|
6
|
Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy.
|
Eur J Haematol
|
2009
|
0.94
|
7
|
ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.
|
Haematologica
|
2011
|
0.91
|
8
|
South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients.
|
Br J Haematol
|
2008
|
0.82
|
9
|
A case of lymphoma presenting as splenic infarction.
|
BMJ Case Rep
|
2009
|
0.75
|